Theravance Story Overview

THRX -- USA Stock  

null 9.81  9.81  9,223,372,036,855%

Macroaxis does not monitor all media channels or aggregates social signals for Theravance. But even though we do not provide professional-grade financial sentiment analysis on Theravance, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Theravance. Also please take a look at World Market Map.
Glaxo-Innoviva Triple Combo Inhaler Positive in Phase III
GlaxoSmithKline plc GSK and partner Innoviva, Inc. INVA announced that its once-daily single inhaler triple therapy - Trelegy Ellipta - met primary endpoint in a phase III IMPACT study, showing ... GSK and Innoviva Report Positive Headline Results from IMPACT Study Showing ... - Business Wire Theravance Biopharma Highlights Positive Headline Results from IMPACT Study of ... - Markets Insider

Read More...   

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for Theravance

few days ago at http://hillaryhq.com 
Senzar Asset Management Lifted By 385344 Its Theravance Biopharma Position Foot Locker Has 0.8 ...
news
Hillary HQ Theravance Biopharma, Inc. Analysts See -1.24 EPS INDOOR HARVEST Shorts Down By 50 The Cardinal Weekly Theravance Biopharma Inc Ordinary Shares Has Increase in Shorts The FanobFull coverage
over two weeks ago at http://cedarvillenews.com 
Theravance Biopharma, Inc. Momentum in Focus as Target Weight For Portfolio Reaches 0.02670
news
Cedarville NewsFull coverage
over a month ago at http://www.streetobserver.com 
Stock Hold Signal Theravance Biopharma, Inc.
news
Street Observer Full coverage
over a month ago at http://www.zacks.com 
Theravance Biopharma Down 1.9 percent Since Earnings Report Can It Rebound
zacks News
Zacks.comWill Theravance Biopharma Inc Ordinary Shares Run Out of Steam Soon Short Interest is Up Frisco FastballYear-to-date in the Limelight Plug Power Inc. , REV Group, Inc. , Theravance ... Stocks News Point Full coverage
over a month ago at http://stocknewstimes.com 
Theravance Biopharma Given Buy Rating at Needham Company LLC
news
StockNewsTimesFull coverage
over a month ago at http://www.prnewswire.com 
Theravance Biopharma Highlights Submission of Regulatory Application in Japan for Once-Daily Single Inhaler Tr...
prnewswire News
PR Newswire Full coverage
over a month ago at http://normanweekly.com 
Theravance Biopharma, Inc. Reaches 22.59 After 7.00 percent Down Move Okta Class A Shorts Raised ...
news
Norman WeeklyCrocs, Inc. Reaches 16.85 After 3.00 percent Up Move 7 Analysts Are Bullish Theravance Biopharma, Inc. TBPH ... FlintDaily.comFull coverage
over two months ago at http://flintdaily.com 
Globant SA Reaches 51.68 After 6.00 percent Up Move Theravance Biopharma Sentiment Is 1.31
news
FlintDaily.comFull coverage
over two months ago at http://news.cmlviz.com 
Swing Trade Earnings Bullish Momentum With Options in Theravance Biopharma Inc
news
CML NewsFull coverage
over two months ago at http://bzweekly.com 
As Mirati Therapeutics Shares Rose, Holder Cormorant Asset Management Lifted Its Position Graco GGG ...
news
BZ WeeklyFull coverage
over two months ago at http://macondaily.com 
Zacks Analysts Expect Theravance Biopharma Inc to Announce -1.31 EPS
news
Macon DailyBanc Funds Co Has Lowered Stake in Dnb Financial by 795.32 Million Theravance Biopharma Sets 52-Week Low Strong Momentum for Sellers Newburgh GazetteFull coverage
over three months ago at http://stocknewstimes.com 
Innoviva Lowered to Sell at Zacks Investment Research
news
StockNewsTimesEyegate Pharmaceuticals versus Innoviva Critical Analysis The Ledger GazetteInnoviva Lifted to B at TheStreet Dispatch TribunalFull coverage
over three months ago at http://financialqz.com 
Coming Out Of Shadows Achillion Pharmaceuticals, Inc. , Innoviva, Inc ...
news
At the session level, shares of Achillion Pharmaceuticals, Inc. moved -0.33 percent from the open. The most recent bid on the stock was registered at 2.99.

Cash and Equivalents

Cash and Equivalents Comparative Analysis
  Cash and Equivalents 
      Theravance Comparables 
Theravance is currently under evaluation in cash and equivalents category among related companies. Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Also please take a look at World Market Map. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">